giants of the era

Chapter 219 Beat the Reserved Dogs!
Biopharmaceutical development costs a lot. Amgen's funds are almost exhausted, but the product is nowhere in sight. If there were no successful examples of Genentech before, investors would have withdrawn their funds long ago.

After the venture capitalist Carl James came to Amgen, he looked at the founder and CEO of the company, Dr. George Ratman, in astonishment, "What?! Lee's Pharmaceuticals invested $7000 million to acquire Amgen? George Dr. Ratman, you are not mistaken?!!"

Dr. George Ratman nodded confidently and said: "It's true, not long ago, Miss Dongfang Yuqin called me personally. After I got the news, I will contact you immediately!"

Genentech has merged into Lee's Pharmaceuticals. It can be said that today's Lee's Pharmaceuticals is a leading company in global biotechnology.

Carl James was overjoyed when he heard the news. At the beginning of 1981, he and two other major investment companies raised a total of 1900 million US dollars as start-up capital, holding a total of 65% of the shares.I never thought that after more than a year, the market value of Amgen, which has not developed any products, has risen to 7000 million US dollars.

"Have you contacted the heads of the other two investment companies?" Carl James asked.

"Naturally, other people will contact us. When they come, let's discuss it together!"

"Ok!"

……

The next day, in Amgen's meeting room, the company's top executives and investors gathered here.

Dr. George Ratterman repeated Lee's $7000 million acquisition of Amgen, then asked, "What do you think?"

Carl James took the lead in saying: "Lee's Pharmaceutical Company is the most advanced biopharmaceutical company in the world. It would be the most suitable for Amgen to merge into this company. In addition, 7000 million US dollars is really a lot!"

Carl James has regretted investing in Amgen for a long time. He didn’t expect that the research and development of biotechnology would not only cost a lot of money, but also take a long time. The money was all burned, but the product was nowhere in sight. Seeing that the investment was going to be wasted , I can't wait for a receiver to appear immediately.

Representatives of the other two venture capital firms nodded in agreement.In fact, they can't last any longer. Who knows that Amgen will be able to develop products in the Year of the Monkey.As a venture capital company, since they have made money now, they will sell it decisively.

Dr. George Ratterman saw that they all agreed, so he could only agree.

So a week later, Lee's Pharmaceuticals fully acquired Amgen.

At the same time, many bio-companies with potential for development around the world were offered to be acquired by Lee's Pharmaceutical Company, and were subsequently acquired one by one.

From mid-August to the end of September, in just over a month, Lee's Pharmaceuticals acquired a total of 8 companies, large and small, at a cost of only US$9 million.In addition, Lee's Pharmaceutical Company is still poaching people with high salaries. Most of the top talents in biotechnology in the 18s were recruited by Lee's Pharmaceutical Company under its own banner.

At this time, everyone couldn't help being shocked by the crazy behavior of Li's Pharmaceutical Company.

Someone laughed and said, "Chronos Li was stimulated and went crazy, right? Johnson & Johnson failed to acquire them, so they frantically acquired these small companies to vent their displeasure!"

On October 10st, Li's Pharmaceutical Company held a press conference. Li Zetian attended the conference and solemnly announced loudly at the conference: "Welcome everyone to attend this press conference. There is only one point: from today, Lee's Pharmaceutical Company officially changed its name to Gene Technology Company. Biotechnology will be the core of Gene Technology Company. A place to solve human disease problems!

I believe that biopharmaceuticals are the future development trend! ! !
"

clap clap clap! ! !
There was thunderous applause at the press conference!
People don't know what's going on! ! !

Biotechnology and genetic engineering are strange and mysterious to people in this era.However, they know that genes are very powerful!Numerous pharmaceutical companies are also paying attention to this press conference. After Li Zetian finished his speech, these companies all fell into deep thought.

The next day, the "Wall Street Journal" reported: "Wall Street's professional evaluation agency originally assessed the market value of Lee's Pharmaceutical Company at 200 billion U.S. dollars, but after Lee's Pharmaceutical Company changed its name to Gene Technology Company, it was highly sought after by investors. Analyst Joseph Ellis claims that the market capitalization of Genentech is at least $250 billion!
Since then, it is not difficult to see that biotechnology concept stocks will be extremely popular in the United States! ! ! "

As soon as the "Wall Street Journal" report came out, many people who had ridiculed Li Zetian before were completely upset.

"What are those idiots on Wall Street? The company changed its name and its market value increased by $50 billion?!"

"Yeah, this group of people is too rubbish!"

"..."

However, there are still many people who look at the issue more impartially.

"It can't be said that way. Genentech, the most powerful biopharmaceutical company in the world, is owned by Lee's Pharmaceutical Company. After that, it acquired biopharmaceutical companies like crazy. The talents and technologies in biology were all acquired by Lee's Pharmaceutical Company. The pharmaceutical field has powerful and unparalleled capabilities. The reason why Wall Street is so optimistic about gene technology companies is not just as simple as changing the name!"

"Hehe, there is no need to explain too much to these people, they are all brainless. Who is Chronos Li, if he is an ordinary person, how can he achieve the achievements he has today?!"

"..."

Gene Technology Company, the scenery is infinite, and there is no second!
At this time, Johnson & Johnson was out of luck, ushering in the most serious crisis in its history!
On October 1982, 10, an unidentified poisoner spiked bottles of Extra Strength Tylenol capsules produced by McNeil Consumer Products, a unit of Johnson & Johnson, with cyanide. Seven people died.

As soon as the news came out, the entire United States was frightened by Tylenol, Johnson & Johnson was hit hard, and its market value plummeted wildly!Tylenol has been the best-selling painkiller in the United States, with a market share of 35%.An American advertising authority even asserted that Johnson & Johnson would no longer be able to sell another product named after 'Tylenol'.

Johnson & Johnson CEO James Burke immediately ordered all of the company's Tylenol to be pulled from stores across the United States.Within six days of the first patient death, Johnson & Johnson recalled all 3100 million vials of Tylenol, the largest recall in retail history!

In fact, Tylenol is not the only drug that is affected. People no longer trust Johnson & Johnson, and naturally they dare not buy other Johnson & Johnson drugs!
Li Zetian was shocked by the news, and was so overjoyed that he couldn't help shouting "God help me!"
Immediately, Li Zetian called Dongfang Yuqin to him.

"Dongfang Yuqin, Johnson & Johnson has encountered a catastrophe, and we must not let go of the opportunity to beat the dog in the water! We used our own publicity channels to expose Johnson & Johnson's drug problems, and even spent some money to ask the media to help Johnson & Johnson "promote" it !"

Dongfang Yuqin smiled knowingly, nodded and said, "Don't worry, Mr. Li, I know how to do it!"

"Okay! Hurry up, Johnson & Johnson must be working hard on public relations now, we can't let them recover so quickly!"

"En!" Dongfang Yuqin immediately took the order and left.

Li Zetian picked up the newspaper at this time, looked at the news on it, and couldn't help but sneered: "Johnson & Johnson, let me see how you escaped my palm this time!!!"

PS: Do you feel less than two shifts a day?

(End of this chapter)